Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Kezar Life Sciences Inc
(NQ:
KZR
)
0.6430
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Kezar Life Sciences Inc
< Previous
1
2
3
4
5
6
Next >
38 Stocks Moving In Wednesday's Mid-Day Session
March 23, 2022
Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted...
Via
Benzinga
Here's Why Kezar Life Sciences Shares Are Moving
March 18, 2022
Kezar Life Sciences Inc (NASDAQ: KZR) shares are trading higher by 5.0% at $16.08 after HC Wainwright & Co. maintained a Buy rating on the stock and raised its price target...
Via
Benzinga
Kezar Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
March 17, 2022
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Appoints Courtney Wallace to its Board of Directors
December 10, 2021
From
Kezar Life Sciences
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD...
Via
Benzinga
80 Biggest Movers From Yesterday
November 17, 2021
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares surged 55% to close at $1.00 on Tuesday as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG)...
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 150 Points; Talkspace Shares Slide
November 16, 2021
Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,239.46 while the NASDAQ rose 0.76% to 15,974.21. The S&P also rose, gaining 0.59% to 4,710.24. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks Rise Amid Upbeat Consumer Strength Data
November 16, 2021
The Dow Jones Industrial Average is extending this morning's gains, up 189 points at last check, while the S&P 500 and Nasdaq Composite are also in the black midday.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: Crude Oil Down 1%; Kezar Life Sciences Shares Surge
November 16, 2021
Midway through trading Tuesday, the Dow traded up 0.25% to 36,176.74 while the NASDAQ rose 0.19% to 15,883.75. The S&P also rose, gaining 0.21% to 4,692.49. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Kezar Life Sciences Stock Is Soaring Today
November 16, 2021
The company reported promising results from a phase 2 study.
Via
The Motley Fool
53 Stocks Moving In Tuesday's Mid-Day Session
November 16, 2021
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) jumped 65.7% to $1.0691 as the company reported a narrower Q3 loss. Progenity, Inc. (NASDAQ: PROG) shares climbed 35.5% to...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher; Walmart Tops Q3 Expectations
November 16, 2021
Following the market opening Tuesday, the Dow traded up 0.40% to 36,231.05 while the NASDAQ rose 0.20% to 15,885.76. The S&P also rose, gaining 0.31% to 4,697.11. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 16, 2021
Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8...
Via
Benzinga
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
November 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 16, 2021
Good morning, trader! Start your day off the right way with a breakdown of the biggest pre-market stock movers for Tuesday.
Via
InvestorPlace
36 Stocks Moving in Tuesday's Pre-Market Session
November 16, 2021
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) rose 63.9% to $1.07 in pre-market trading as the company reported a narrower Q3 loss. Kezar Life Sciences, Inc. (NASDAQ:...
Via
Benzinga
Small-cap Biopharma Kezar Life Sciences Is Soaring, Here's Why
November 16, 2021
Kezar Life Sciences, Inc. (NASDAQ: KZR) shares are soaring Tuesday following a positive clinical readout. What Happened: California-based Kezar announced...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 15, 2021
Gainers Kezar Life Sciences (NASDAQ:KZR) s...
Via
Benzinga
Kezar Life Sciences Announces Interim Results from the MISSION Phase 2 Trial in Patients with Lupus Nephritis
November 15, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at...
Via
Benzinga
Exposures
Product Safety
Kezar Life Sciences to Present at the Jefferies London Healthcare Conference
November 11, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Oxford Finance Provides $50 Million Credit Facility to Kezar Life Sciences, Inc.
November 10, 2021
From
Oxford Finance LLC
Via
Business Wire
Kezar Reports Third Quarter Financial Results and Provides Business Update
November 09, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar to Host Virtual Investor and Analyst Day on November 15, 2021
November 03, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Announces First Patient Dosed in Phase 1 Trial of KZR-261 in Advanced Solid Tumor Malignancies
October 27, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
Kezar Life Sciences Appoints Gitanjali Jain as Vice President, Investor Relations and External Affairs
October 05, 2021
From
Kezar Life Sciences, Inc.
Via
Business Wire
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
September 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
46 Biggest Movers From Yesterday
September 15, 2021
Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 14, 2021
Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 40.5...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.